<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="50114">Estrogen</z:chebi>-receptor-beta (ERβ), <z:chebi fb="28" ids="17026">progesterone</z:chebi> receptor (PR) and vascular endothelial growth factor (VEGF-A) have been implicated in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>However, the clinicopathological significance of any expression of these markers remains unclear </plain></SENT>
<SENT sid="2" pm="."><plain>Immunohistochemical assays of ERα, ERβ, PR, and VEGF-A were performed on 72 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> cases </plain></SENT>
<SENT sid="3" pm="."><plain><z:mpath ids='MPATH_458'>Normal</z:mpath> mucosa from the same cases was assessed as a control </plain></SENT>
<SENT sid="4" pm="."><plain>The correlation of presence of these markers with clinicopathological features and survival was determined </plain></SENT>
<SENT sid="5" pm="."><plain>ERα and PR were not expressed in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>Forty-one of 53 (77.4%) cases of <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa showed strong ERβ expression compared with weak expression in 32 of 72 (44.4%) of malignant cells </plain></SENT>
<SENT sid="7" pm="."><plain>A significant decrease in ERβ expression from <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa to <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was found in females (P = 0.007) but not in males (P = 0.149) </plain></SENT>
<SENT sid="8" pm="."><plain>VEGF-A was expressed strongly in malignant cells in 64 of 72 (89%) cases </plain></SENT>
<SENT sid="9" pm="."><plain>No association was found between ERβ or VEGF-A expression and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> grade, angiolymphatic involvement, stage, disease-free survival, or overall survival </plain></SENT>
<SENT sid="10" pm="."><plain><z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">Colorectal cancers</z:e> do not express ERα or PR </plain></SENT>
<SENT sid="11" pm="."><plain>ERβ may have a protective role, especially in females </plain></SENT>
<SENT sid="12" pm="."><plain>VEGF-A may have a role in <z:mp ids='MP_0002006'>tumorigenesis</z:mp> </plain></SENT>
<SENT sid="13" pm="."><plain>Nevertheless, ERβ and VEGF-A cannot be used as prognostic markers </plain></SENT>
</text></document>